Celldex Therapeutics’ $230.5 Million Common Stock Offering

Leila Ahmed North America Legal Chronicle
Tagged:

Lowenstein Sandler advised Celldex Therapeutics, Inc. on the offering, and Wilmer Cutler Pickering Hale and Dorr advised the underwriters.Celldex Therapeutics, Inc. (Nasdaq: CLDX) (“Celldex”) announced the public…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here